Benefits and Costs of Biosafety Regulation in India and China
Carl E. Pray,
Bharat Ramaswami and
Additional contact information
Carl E. Pray: Rutgers University
Ruifa Hu: Chinese Academy of Science
Qihuai Wang: Chinese Ministry of Agriculture
Prajakta Bengali: Marketics Technologies India Pvt. Ltd.
Chapter Chapter 22 in Regulating Agricultural Biotechnology: Economics and Policy, 2006, pp 481-508 from Springer
Abstract Developing countries are rushing to build effective biosafely regulatory systems in response to the spread of genetically modified organisms. So far, few of them have considered the costs and benefits of building and implementing such a system. This chapter takes a modest step in that direction by listing some of the possible costs and benefits of regulation and then giving some examples of costs and benefits to regulation in India and China. It finds that private firms’ costs of complying with biosafety regulations for Bt cotton have been substantial in India but much less in China. On the benefits side the paper provides a detailed example of economic benefits from restricting unapproved genes in China and evidence that a transparent regulatory system might increase the demand for GM products.
Keywords: regulation; biotechnology costs; India; China (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (3) Track citations by RSS feed
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:spr:nrmchp:978-0-387-36953-2_22
Ordering information: This item can be ordered from
Access Statistics for this chapter
More chapters in Natural Resource Management and Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().